CNET on MSN5mon
Abbott Warns Small Number of FreeStyle Libre 3 Sensors May Give Inaccurate Readings
Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's ...
drugdeliverybusiness1d
Abbott, Dexcom settle global CGM patent litigation
Abbott (NYSE:ABT) reached an agreement with Dexcom (Nasdaq:DXCM) to settle all outstanding patent disputes between companies.
GlobalData on MSN3mon
FDA hits Abbott FreeStyle Libre 3 recall with Class I tag
The US Food and Drug Administration (FDA) has tagged Abbott’s recent recall of its faulty FreeStyle Libre 3 sensors as Class ...
pharmaphorum2d
Real-time Abbott glucose monitor available to NHS after UK launch
Meanwhile, the UK launch of Freestyle Libre 3 comes as rival real-time CGM player Dexcom received a European CE mark for its G7 device for people with diabetes aged two years and older.